Making losses count

Even though Congress continues to argue over the future of large-scale tax reform, a small business interest group is pushing several proposals that could inject as much as $20 billion annually into pre-profit R&D companies in biotech and other sectors, according to an economic analysis conducted by Ernst & Young.